Cargando…

Utility of Blood Cellular Indices in the Risk Stratification of Patients Presenting with Acute Pulmonary Embolism

Pulmonary embolism (PE) clinical manifestations vary widely, and that scope is not fully captured by current all-cause mortality risk models. PE is associated with inflammatory, coagulation, and hemostatic imbalances so blood cellular indices may be prognostically useful. Complete blood count (CBC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slajus, Brett, Brailovsky, Yevgeniy, Darwish, Iman, Fareed, Jawed, Darki, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649084/ https://www.ncbi.nlm.nih.gov/pubmed/34846193 http://dx.doi.org/10.1177/10760296211052292

Ejemplares similares

Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism
por: Darwish, Iman, et al.
Publicado: (2022)

Biomarkers of Thrombo-Inflammatory Responses in Pulmonary Embolism Patients With Pre-Existing Versus New-Onset Atrial Fibrillation
por: Patel, Dimpi, et al.
Publicado: (2021)

Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19
por: Marginean, Alexandru, et al.
Publicado: (2020)

Fibrinolytic Status and Risk of Death After Acute Pulmonary Embolism
por: Brailovsky, Yevgeniy, et al.
Publicado: (2023)

Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism
por: Phan, Trung, et al.
Publicado: (2020)

Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism
por: O’Hara, Alexander, et al.
Publicado: (2023)

The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Upregulation of Inflammatory Cytokines in Pulmonary Embolism Using Biochip-Array Profiling
por: Bontekoe, Emily, et al.
Publicado: (2021)

Acute submassive pulmonary embolism after SARS-CoV-2 infection: a case report of reinfection or prolonged hypercoagulable state
por: Pow, Timothy, et al.
Publicado: (2021)

The Relationship Between Thrombo-Inflammatory Biomarkers and Cellular Indices of Inflammation in Lymphoma Patients
por: Jaradeh, Mark, et al.
Publicado: (2021)

Collagen Remodeling and Fatty Acid Regulation Biomarkers in Understanding the Molecular Pathogenesis of Atrial Fibrillation
por: Odeh, Ameer, et al.
Publicado: (2022)

Interrelationship Between Inflammatory Biomarkers and Collagen Remodeling Proteins in Atrial Fibrillation
por: Odeh, Ameer, et al.
Publicado: (2023)

Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism
por: Siddiqui, Fakiha, et al.
Publicado: (2022)

Right Ventricular Outflow Doppler Predicts Low Cardiac Index in Intermediate Risk Pulmonary Embolism
por: Brailovsky, Yevgeniy, et al.
Publicado: (2019)

Association Between the Severity of Obstructive Sleep Apnea and the Risk Stratification of Acute Pulmonary Embolism
por: Chen, Jiayue, et al.
Publicado: (2023)

Case report of a metastatic squamous cell carcinoma to the pericardium masquerading as ST elevation myocardial infarction on ECG
por: Brailovsky, Yevgeniy, et al.
Publicado: (2018)

Neurological Complications of Pulmonary Embolism: a Literature Review
por: Desai, Parth V., et al.
Publicado: (2021)

Paradoxical Embolism Causing Myocardial Infarction in a COVID-19 Patient Presenting With Pulmonary Embolism
por: Yu, Mingxi D, et al.
Publicado: (2021)

Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors—An In Vitro Study
por: Schultz, Nina Haagenrud, et al.
Publicado: (2021)

A rare case of miliary tuberculosis presenting with saddle pulmonary embolism
por: Malik, M. Kasim, et al.
Publicado: (2023)

Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory Biomarkers
por: Poredoš, Pavel, et al.
Publicado: (2023)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

National Trends for Peripheral Artery Disease and End Stage Renal Disease From the National Inpatient Sample Database
por: De Stefano, Frank, et al.
Publicado: (2021)

Pulmonary Cement Embolism After Vertebroplasty
por: Malik, Muhammad K, et al.
Publicado: (2023)

The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients
por: Allen, Madeline, et al.
Publicado: (2023)

Silent Pulmonary Embolism in Deep Vein Thrombosis: Relationship and Risk Factors
por: Shi, Yadong, et al.
Publicado: (2022)

Relationship Between 25-Hydroxyvitamin D, Renin, and Collagen Remodeling Biomarkers in Atrial Fibrillation
por: Patel, Dimpi, et al.
Publicado: (2020)

Arterial-renal Syndrome in Patients with ESRD, a New Disease Paradigm
por: Goldstein, Jake, et al.
Publicado: (2022)

Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients
por: Laouan Brem, Falmata, et al.
Publicado: (2021)

Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 Pandemic
por: Doan, Thao, et al.
Publicado: (2022)

Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin
por: Olson, Guy, et al.
Publicado: (2023)

A Feasibility Study on the Identification of Potential Biomarkers in Pulmonary Embolism Using Proteomic Analysis
por: Granholm, Fredrik, et al.
Publicado: (2022)

Derivation and Validation of a Prognostic Model for Mortality in Chinese Patients with Acute Pulmonary Embolism
por: Zhang, Jiarui, et al.
Publicado: (2022)

Frequency of Thrombotic Risk Factors in Patients with Chronic Thromboembolic Pulmonary Hypertension and Acute Pulmonary Embolism: A Case-Control Study
por: Dodson, Mark W., et al.
Publicado: (2022)

Submassive Pulmonary Embolism Complicating Small Bowel Obstruction
por: Sagalov, Andrew, et al.
Publicado: (2021)

Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey
por: Kantarcioglu, Bulent, et al.
Publicado: (2021)

Regulation of Cortisol in Patients Undergoing Total Joint Arthoplasty
por: Khanna, Rajan, et al.
Publicado: (2021)

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis
por: Mehrotra, Siddharth, et al.
Publicado: (2022)

The Predictor Potential Role of the Glucose to Potassium Ratio in the Diagnostic Differentiation of Massive and Non-Massive Pulmonary Embolism
por: Boyuk, Ferit
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ufbfi8gb7jsgheep3ef5pfnnm0